Literature DB >> 24190490

Deregulated expression of circadian clock and clock-controlled cell cycle genes in chronic lymphocytic leukemia.

Sobia Rana1, Mustafa Munawar, Adeela Shahid, Meera Malik, Hafeez Ullah, Warda Fatima, Shahida Mohsin, Saqib Mahmood.   

Abstract

Circadian rhythms are endogenous and self-sustained oscillations of multiple biological processes with approximately 24-h rhythmicity. Circadian genes and their protein products constitute the molecular components of the circadian oscillator that form positive/negative feedback loops and generate circadian rhythms. The circadian regulation extends from core clock genes to various clock-controlled genes that include various cell cycle genes. Aberrant expression of circadian clock genes, therefore, may lead to genomic instability and accelerated cellular proliferation potentially promoting carcinogenesis. The current study encompasses the investigation of simultaneous expression of four circadian clock genes (Bmal1, Clock, Per1 and Per2) and three clock-controlled cell cycle genes (Myc, Cyclin D1 and Wee1) at mRNA level and determination of serum melatonin levels in peripheral blood samples of 37 CLL (chronic lymphocytic leukemia) patients and equal number of age- and sex-matched healthy controls in order to indicate association between deregulated circadian clock and manifestation of CLL. Results showed significantly down-regulated expression of Bmal1, Per1, Per2 and Wee1 and significantly up-regulated expression of Myc and Cyclin D1 (P < 0.0001) in CLL patients as compared to healthy controls. When expression of these genes was compared between shift-workers and non-shift-workers within the CLL group, the expression was found more aberrant in shift-workers as compared to non-shift-workers. However, this difference was found statistically significant for Myc and Cyclin D1 only (P < 0.05). Serum melatonin levels were found significantly low (P < 0.0001) in CLL subjects as compared to healthy controls whereas melatonin levels were found still lower in shift-workers as compared to non-shift-workers within CLL group (P < 0.01). Our results suggest that aberrant expression of circadian clock genes can lead to aberrant expression of their downstream targets that are involved in cell proliferation and apoptosis and hence may result in manifestation of CLL. Moreover, shift-work and low melatonin levels may also contribute in etiology of CLL by further perturbing of circadian clock.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24190490     DOI: 10.1007/s11033-013-2841-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  43 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Coordination of circadian timing in mammals.

Authors:  Steven M Reppert; David R Weaver
Journal:  Nature       Date:  2002-08-29       Impact factor: 49.962

Review 3.  B-cell chronic lymphocytic leukemia: a bird of a different feather.

Authors:  F Caligaris-Cappio; T J Hamblin
Journal:  J Clin Oncol       Date:  1999-01       Impact factor: 44.544

Review 4.  Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis.

Authors:  H Döhner; S Stilgenbauer; K Döhner; M Bentz; P Lichter
Journal:  J Mol Med (Berl)       Date:  1999-02       Impact factor: 4.599

5.  CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses.

Authors:  Aaron E Hoffman; Chun-Hui Yi; Tongzhang Zheng; Richard G Stevens; Derek Leaderer; Yawei Zhang; Theodore R Holford; Johnni Hansen; Jennifer Paulson; Yong Zhu
Journal:  Cancer Res       Date:  2010-02-02       Impact factor: 12.701

6.  Correlated downregulation of estrogen receptor beta and the circadian clock gene Per1 in human colorectal cancer.

Authors:  Nazanin Mostafaie; Enikö Kállay; Elisabeth Sauerzapf; Elisabeth Bonner; Stefan Kriwanek; Heide S Cross; Klaus Roland Huber; Walter Krugluger
Journal:  Mol Carcinog       Date:  2009-07       Impact factor: 4.784

Review 7.  Minireview: Cyclin D1: normal and abnormal functions.

Authors:  Maofu Fu; Chenguang Wang; Zhiping Li; Toshiyuki Sakamaki; Richard G Pestell
Journal:  Endocrinology       Date:  2004-08-26       Impact factor: 4.736

8.  Melatonin and 6-sulfatoxymelatonin circadian rhythms in serum and urine of primary prostate cancer patients: evidence for reduced pineal activity and relevance of urinary determinations.

Authors:  C Bartsch; H Bartsch; A Schmidt; S Ilg; K H Bichler; S H Flüchter
Journal:  Clin Chim Acta       Date:  1992-08-31       Impact factor: 3.786

Review 9.  Melatonin as a biomarker of circadian dysregulation.

Authors:  Dana K Mirick; Scott Davis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

Review 10.  Finding new clock components: past and future.

Authors:  Joseph S Takahashi
Journal:  J Biol Rhythms       Date:  2004-10       Impact factor: 3.182

View more
  25 in total

1.  Construction of a plasmid for overexpression of human circadian gene period2 and its biological activity in osteosarcoma cells.

Authors:  An-yuan Cheng; Yan Zhang; Hong-jun Mei; Shuo Fang; Peng Ji; Jian Yang; Ling Yu; Wei-chun Guo
Journal:  Tumour Biol       Date:  2015-01-07

Review 2.  Complementary and Integrative Medicine in Hematologic Malignancies: Questions and Challenges.

Authors:  Moshe Frenkel; Kenneth Sapire
Journal:  Curr Oncol Rep       Date:  2017-10-14       Impact factor: 5.075

Review 3.  Circadian gene variants in cancer.

Authors:  Nicole M Kettner; Chinenye A Katchy; Loning Fu
Journal:  Ann Med       Date:  2014-06-05       Impact factor: 4.709

4.  Normalization of disrupted clock gene expression in males with tetraplegia: a crossover randomized placebo-controlled trial of melatonin supplementation.

Authors:  Emil Kostovski; Elena Frigato; Mladen Savikj; Anders Dahm; Per Morten Sandset; Marie-Christine Mowinckel; Grethe Skretting; Bjarne Østerud; Cristiano Bertolucci; Per Ole Iversen
Journal:  Spinal Cord       Date:  2018-07-09       Impact factor: 2.772

Review 5.  PER2: a potential molecular marker for hematological malignancies.

Authors:  Huihui Jiang; Xin Yang; Miaomiao Mi; Xiaonan Wei; Hongyuan Wu; Yu Xin; Chengming Sun
Journal:  Mol Biol Rep       Date:  2021-10-12       Impact factor: 2.316

Review 6.  Circadian Influence on Metabolism and Inflammation in Atherosclerosis.

Authors:  Cameron S McAlpine; Filip K Swirski
Journal:  Circ Res       Date:  2016-06-24       Impact factor: 17.367

Review 7.  Melatonin: does it have utility in the treatment of haematological neoplasms?

Authors:  Tian Li; Zhi Yang; Shuai Jiang; Wencheng Di; Zhiqiang Ma; Wei Hu; Fulin Chen; Russel J Reiter; Yang Yang
Journal:  Br J Pharmacol       Date:  2017-09-09       Impact factor: 8.739

8.  Circadian regulation of c-MYC in mice.

Authors:  Zhenxing Liu; Christopher P Selby; Yanyan Yang; Laura A Lindsey-Boltz; Xuemei Cao; Khagani Eynullazada; Aziz Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-19       Impact factor: 11.205

Review 9.  Cancer in the Fourth Dimension: What Is the Impact of Circadian Disruption?

Authors:  Marie Pariollaud; Katja A Lamia
Journal:  Cancer Discov       Date:  2020-09-15       Impact factor: 38.272

10.  Carcinogenic effects of circadian disruption: an epigenetic viewpoint.

Authors:  Abbas Salavaty
Journal:  Chin J Cancer       Date:  2015-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.